ClinConnect ClinConnect Logo
Search / Trial NCT06516172

The Bern Rehab Registry

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Jul 17, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Rehabilitation Prevention Physical Function Mental Function Participation Disabilities

ClinConnect Summary

The Bern Rehab Registry study is looking at how a rehabilitation program can help people with long-term health issues like cancer, heart disease, lung disease, or musculoskeletal problems. This program may involve different options, such as staying in a healthcare facility, visiting for appointments, receiving care at home with the help of technology (called telerehabilitation), or a mix of these methods. The goal is to see how these rehabilitation approaches improve patients' physical health, strength, and emotional well-being, as well as their overall quality of life.

To participate in this study, you must be at least 18 years old and have a chronic health condition that requires rehabilitation. You’ll need to give your consent to use your health information for this research. If you join, you can expect to share your experiences and health outcomes, which will help researchers understand how effective these rehabilitation programs are and how new technologies are being used. Your participation could lead to better care for others facing similar health challenges in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years and older with a chronic non-communicable disease
  • Signed general informed consent
  • Referral to a comprehensive disease-specific rehabilitation program
  • Exclusion Criteria:
  • Refuted or missing general informed consent for further use of health-related data and samples.

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Heiligenschwendi, Bern, Switzerland

Bern, , Switzerland

Patients applied

0 patients applied

Trial Officials

Matthias Wilhelm, MD

Principal Investigator

Centre for Rehabilitation & Sports Medicine, Insel Group

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported